CME for Medical Pre-Con Symposium
Gaps in Hemophilia Inhibitor Testing Practices and Building Solutions
A Provider Collaborative Learning Exchange
Gaylord Rockies Resort & Convention Center in Aurora, Colorado.
Thursday, August 21, 2025, from 2:00 PM – 5:10 PM (MT)
Jointly provided by Partners for Advancing Clinical Education and NBDF
Target Audience
This activity is intended for U.S. physicians, physician assistants, DOs, and nurse practitioners who care for patients with hemophilia A and B. [Please note that this event is an educational symposium for US prescribers only, due to ensuring the confidential nature of planned group discussions.]
Educational Objectives
At the conclusion of this activity, the participants should be better able to:
-
Describe current state of inhibitor testing methodology.
-
Identify gaps in inhibitor testing among patients with hemophilia with reported factor concentrate utilization
-
Discuss barriers to inhibitor testing practice.
-
Collaborate with hematologist attendees to identify solutions to barriers and promote inhibitor testing among all persons with hemophilia receiving clotting factor concentrates.
Faculty
Amy L. Dunn, MD
Professor of Pediatrics
Director of Pediatric Hematology
Hemophilia Treatment Center
Nationwide Children’s Hospital
The Ohio State University College of Medicine
Columbus, Ohio
Bhavya S. Doshi, MD
Assistant Professor of Pediatrics
Aflac Cancer and Blood Disorders Center
Emory University School of Medicine
Children's Healthcare of Atlanta
Atlanta, Georgia
Kate Nammacher, MPH
Senior Vice President of Education
National Bleeding Disorders Foundation
New York, New York
Disclosure of Conflicts of Interest
Partners requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships are mitigated according to Partners policies.
Program Agenda
2:00 PM – 2:05 PM Welcome & Introduction
Amy Dunn, MD, moderator
2:05 PM – 2:15 PM Pre-activity assessment
2:15 PM – 2:40 PM Current Inhibitor Testing Methodology and Assays
Bhavya Doshi, MD
2:40 PM – 2:55 PM Review of Community Counts Registry Inhibitor Report Data
Kate Nammacher, MPH
2:55 PM – 3:05 PM Break
3:05 PM – 3:35 PM Group Discussion 1 on testing among females
3:35 PM – 4:05 PM Group Discussion 2 on testing of young children
4:05 PM – 4:35 PM Group Discussion 3 on testing in mild hemophilia patients
4:35 PM – 4:50 PM Post-assessment and CME instructions
4:50 PM – 5:00 PM Closing Remarks
5:10 PM Adjournment
Americans with Disabilities Act
Event staff will be glad to assist you with any particular accommodation needs (i.e., physical, dietary, etc). Please email NBDF’s Conference & Travel Services Department prior to the live conference at bdc@bleeding.org.
Fee Information
All prescribers must have a confirmed registration for NBDF's Bleeding Disorders Conference to attend this Medical Pre-con. Please CLICK HERE to view our registration fees. There is no additional fee to attend this educational symposium.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (Partners) and NBDF. Partners is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Education
Partners designates this live activity for a maximum of 3.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This project is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $500,000 with 100 percent funded by CDC/HHS. The contents are solely those of the author(s) and do not necessarily represent the official views, nor an endorsement, by CDC/HHS or the U.S. Government.
Copyright 2025. All rights reserved.
Organized by NBDF - Conference and Travel Services Department